Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 415243, 10 pages
http://dx.doi.org/10.1155/2015/415243
Research Article

TCM Formula Xiaoyaosan Decoction Improves Depressive-Like Behaviors in Rats with Type 2 Diabetes

School of Basic Medical Science, Beijing University of Chinese Medicine, Beijing 100029, China

Received 11 February 2015; Revised 30 April 2015; Accepted 30 April 2015

Academic Editor: Francis B. Lewu

Copyright © 2015 Na Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. D. Goldney, P. J. Phillips, L. J. Fisher, and D. H. Wilson, “Diabetes, depression, and quality of life: a population study,” Diabetes Care, vol. 27, no. 5, pp. 1066–1070, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. P. J. Lustman, R. J. Anderson, K. E. Freedland, M. de Groot, R. M. Carney, and R. E. Clouse, “Depression and poor glycemic control: a meta-analytic review of the literature,” Diabetes Care, vol. 23, no. 7, pp. 934–942, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. J. S. Gonzalez, S. A. Safren, E. Cagliero et al., “Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity,” Diabetes Care, vol. 30, no. 9, pp. 2222–2227, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Hutter, A. Schnurr, and H. Baumeister, “Healthcare costs in patients with diabetes mellitus and comorbid mental disorders—a systematic review,” Diabetologia, vol. 53, no. 12, pp. 2470–2479, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Li, E. S. Ford, G. Zhao, L. S. Balluz, J. T. Berry, and A. H. Mokdad, “Undertreatment of mental health problems in adults with diagnosed diabetes and serious psychological distress: the behavioral risk factor surveillance system, 2007,” Diabetes Care, vol. 33, no. 5, pp. 1061–1064, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. R. J. Anderson, K. E. Freedland, R. E. Clouse, and P. J. Lustman, “The prevalence of comorbid depression in adults with diabetes: a meta-analysis,” Diabetes Care, vol. 24, no. 6, pp. 1069–1078, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Ali, M. A. Stone, J. L. Peters, M. J. Davies, and K. Khunti, “The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis,” Diabetic Medicine, vol. 23, no. 11, pp. 1165–1173, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Sarkar and Y. P. Balhara, “Diabetes mellitus and suicide,” Indian Journal of Endocrinology and Metabolism, vol. 18, no. 4, pp. 468–474, 2014. View at Publisher · View at Google Scholar
  9. M. T. Li and H. Xiang, “Advances in effective ingredients and pharmacological action of Xiaoyao Pill or Xiaoyao San research,” Journal of Chinese Medicinal Materials, vol. 33, no. 12, pp. 1968–1972, 2010. View at Google Scholar
  10. D. R. Gehlert, “Role of hypothalamic neuropeptide Y in feeding and obesity,” Neuropeptides, vol. 33, no. 5, pp. 329–338, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Sainsbury, F. Rohner-Jeanrenaud, E. Grouzmann, and B. Jeanrenaud, “Acute intracerebroventri-cular administration of neuropeptide Y stimulates corticosterone output and feeding but not insulin output in normal rats,” Neuroendocrinology, vol. 63, no. 4, pp. 318–326, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Liu, Y. Zhang, M. Han, Z. Liu, J. Wang, and Q. He, “Chinese herbal formula Xiao Yao San for treatment of depression: a systematic review of randomized controlled trials,” Evidence-based Complementary and Alternative Medicine, vol. 2012, Article ID 931636, 13 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. X. K. Qin, P. Li, M. Han, Z. J. Liu, and J. P. Liu, “Systematic review of randomize controlled trials of Xiaoyao Powder in treatment of depression,” Journal of Traditional Chinese Medicine, vol. 51, no. 6, pp. 500–505, 2010. View at Google Scholar
  14. B. Ji, J. X. Chen, Z. L. Lu, L. S. Hu, X. Wan, and S. P. Chang, “Investigation of the scope of macroscopic indications related with the syndrome represented by Xiaoyao powder,” Journal of Beijing University of Traditional Chinese Medicine, vol. 26, no. 5, pp. 70–73, 2003. View at Google Scholar
  15. H. Ni, G. Liu, and S. Luo, “Clinical study in treating type 2 diabetes mellitus according to liver in TCM,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 20, no. 8, pp. 577–579, 2000. View at Google Scholar · View at Scopus
  16. X. B. Wang, B. Xie, Z. Y. Zhou et al., “Effects of Danzhi xiaoyao decoction on insulin receptors and insulin receptor substrate-1 mRNA expression in diabetes mellitus rat with depression,” Chinese Journal of Gerontology, vol. 4, no. 7, pp. 1181–1183, 2011. View at Google Scholar
  17. J.-X. Chen, Y.-T. Tang, and J.-X. Yang, “Changes of glucocorticoid receptor and levels of CRF mRNA, POMC mRNA in brain of chronic immobilization stress rats,” Cellular and Molecular Neurobiology, vol. 28, no. 2, pp. 237–244, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. S.-X. Wang, J.-X. Chen, G.-X. Yue, M.-H. Bai, M.-J. Kou, and Z.-Y. Jin, “Xiaoyaosan decoction regulates changes in neuropeptide y and leptin receptor in the rat arcuate nucleus after chronic immobilization stress,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 381278, 16 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. J. X. Chen and Y. T. Tang, “Change of relative brain zone POMC gene expression and effect of Chinese medicine on chronic restrained stress model rats,” Chinese Remedies & Clinics, vol. 3, no. 3, pp. 223–226, 2003. View at Google Scholar
  20. J.-X. Chen, W. Li, X. Zhao, and J.-X. Yang, “Effects of the Chinese traditional prescription Xiaoyaosan decoction on chronic immobilization stress-induced changes in behavior and brain BDNF, TrkB, and NT-3 in rats,” Cellular and Molecular Neurobiology, vol. 28, no. 5, pp. 745–755, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. R. S. Duman, G. R. Heninger, and E. J. Nestler, “A molecular and cellular theory of depression,” Archives of General Psychiatry, vol. 54, no. 7, pp. 597–606, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. Q.-Q. Mao, S.-P. Ip, K.-M. Ko, S.-H. Tsai, Y.-F. Xian, and C.-T. Che, “Effects of peony glycosides on mice exposed to chronic unpredictable stress: further evidence for antidepressant-like activity,” Journal of Ethnopharmacology, vol. 124, no. 2, pp. 316–320, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Xu, B. S. Ku, H. Y. Yao et al., “Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats,” Pharmacology Biochemistry and Behavior, vol. 82, no. 1, pp. 200–206, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. F. M. Qiu, X. M. Zhong, Q. Q. Mao, and Z. Huang, “The antidepressant-like effects of paeoniflorin in mouse models,” Experimental and Therapeutic Medicine, vol. 5, no. 4, pp. 1113–1116, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. W.-S. Wu, “ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a,” Oncogene, vol. 22, no. 7, pp. 955–963, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Zhao, W. Wang, H. Guo, and D. Zhou, “Antidepressant-like effect of liquiritin from Glycyrrhiza uralensis in chronic variable stress induced depression model rats,” Behavioural Brain Research, vol. 194, no. 1, pp. 108–113, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Miao, B. Cheng, and M. Li, “Effect of curcumin on diabetic rat model of cerebral ischemia,” Pakistan Journal of Pharmaceutical Sciences, vol. 28, no. 1, pp. 401–405, 2015. View at Google Scholar
  28. J. Fu, Y. Li, L. Wang, B. Gao, N. Zhang, and Q. Ji, “Paeoniflorin prevents diabetic nephropathy in rats,” Comparative Medicine, vol. 59, no. 6, pp. 557–566, 2009. View at Google Scholar · View at Scopus
  29. K. Rashid and P. C. Sil, “Curcumin enhances recovery of pancreatic islets from cellular stress induced inflammation and apoptosis in diabetic rats,” Toxicology and Applied Pharmacology, vol. 282, no. 3, pp. 297–310, 2015. View at Publisher · View at Google Scholar
  30. R. Afrin, S. Arumugam, V. Soetikno et al., “Curcumin ameliorates streptozotocin-induced liver damage through modulation of endoplasmic reticulum stress-mediated apoptosis in diabetic rats,” Free Radical Research, vol. 49, no. 3, pp. 279–289, 2015. View at Publisher · View at Google Scholar
  31. E. Blomstrand, “A role for branched-chain amino acids in reducing central fatigue,” Journal of Nutrition, vol. 136, no. 2, pp. 544S–547S, 2006. View at Google Scholar · View at Scopus
  32. V. Lozeva-Thomas, “Serotonin brain circuits with a focus on hepatic encephalopathy,” Metabolic Brain Disease, vol. 19, no. 3-4, pp. 413–420, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. J. N. Crawley, “Exploratory behavior models of anxiety in mice,” Neuroscience & Biobehavioral Reviews, vol. 9, no. 1, pp. 37–44, 1985. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Maroun and G. Richter-Levin, “Exposure to acute stress blocks the induction of long-term potentiation of the amygdala-prefrontal cortex pathway in vivo,” The Journal of Neuroscience, vol. 23, no. 11, pp. 4406–4409, 2003. View at Google Scholar · View at Scopus
  35. B. S. McEwen, “Glucocorticoids, depression, and mood disorders: structural remodeling in the brain,” Metabolism, vol. 54, no. 5, pp. 20–23, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Maheux, F. Ducros, J. Bourque, J. Garon, and J.-L. Chiasson, “Fluoxetine improves insulin sensitivity in obese patients with non-insulin-dependent diabetes mellitus independently of weight loss,” International Journal of Obesity, vol. 21, no. 2, pp. 97–102, 1997. View at Publisher · View at Google Scholar · View at Scopus
  37. V. M. Connolly, A. Gallagher, and C. M. Kesson, “A study of fluoxetine in obese elderly patients with type 2 diabetes,” Diabetic Medicine, vol. 12, no. 5, pp. 416–418, 1995. View at Publisher · View at Google Scholar · View at Scopus
  38. R. S. Surwit, M. A. L. Van Tilburg, N. Zucker et al., “Stress management improves long-term glycemic control in type 2 diabetes,” Diabetes Care, vol. 25, no. 1, pp. 30–34, 2002. View at Publisher · View at Google Scholar · View at Scopus